A new Coronavirus (SARS-CoV-2) emerged in Wuhan Province, China in December 2019 and rapidly spread around the world. To date, the data in the literature regarding the clinical and epidemiological characteristics of severe forms of CoVid-19 in patients with chronic respiratory disease are not well known. The hypothesis is that patients with chronic respiratory disease (COPD, asthma, bronchial dilatations, pulmonary hypertension, cystic fibrosis, obesity-hypoventilation syndrome, obstructive sleep apnea syndrome) infected with SARS-Cov-2 will have increased dyspnea and hypoxemia leading to hospitalization for severe forms more frequently than the general population. However, they do not appear to be more at risk of developing a critical form. This study is carried out in order to propose to estimate the prevalence of critical forms of CoVid19 among patients with chronic respiratory diseases hospitalized for severe forms.
Study Type
OBSERVATIONAL
Enrollment
617
There will be no intervention. It is only an observationnal study
Valentin Simon
Vandœuvre-lès-Nancy, France
Percentage of patients who reached, during their hospitalization, a value greater than or equal to 6 on the WHO CoVid-19 infection progression scale
Value of 6 or greeter on WHO CoVid-19 scale, indicating of a critical form of CoVid-19.
Time frame: up to 28 days (during hospitalisation)
Determined potential predictive factors of critic form in patients with chronic lung diseases
Radiological damage (extension of ground-glass) could be a predictive factor.
Time frame: up to 28 days (during hospitalisation)
Determined percentage of death
intra-hospital death, intra-ICU death
Time frame: up to 28 days (during hospitalisation)
Determined duration of oxygen therapy
in days (or duration at a different flow rate compared to long-term home oxygen therapy prior to hospitalization)
Time frame: up to 28 days (during hospitalisation)
Determined duration of hospitalization
in days for patients with chronic respiratory disease between the date of admission and the date of discharge. Patients who died during hospitalization will be assigned the highest cohort value.
Time frame: up to 28 days (during hospitalisation)
Determine mean values of the WHO CoVid-19 infection progression scale measured
values will be measured at D3, D7 and D14 in each of the groups. Patients who do not reach D7 and D14 will have the last postponement
Time frame: up to 28 days (during hospitalisation)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.